Vicor VICR 深 沪
等待开盘 12-16 09:30:00 美东时间
97.02
-0.780
-0.80%
华盛通- 最 高99.24
- 今 开98.05
- 成交量 23.31万股
- 最 低 95.5101
- 昨 收 97.80
- 总市值 43.58亿
- 52周最高 102.19
- 市盈率 静 714.96
- 换手率 0.52%
- 52周最低 38.925
- 委 比 94.29%
- 总股本 4491.93万
- 历史最高 164.76
- 量 比 0.90
- 振 幅 3.81%
- 历史最低 4.72
- 每 手 1
- 风险率 15.43%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Shares of electrical equipment companies are trading lower amid overall market weakness.
Shares of electrical equipment companies are trading lower amid overall market ...
12-13 04:54
Vicore Pharma to Present at Nordic Healthcare Conference
Vicore Pharma Holding AB ( ($SE:VICO) ) has provided an announcement. Vicore Ph...
11-20 15:36
Vicore Pharma Raises $48 Million to Expand IPF Trial
An update from Vicore Pharma Holding AB ( ($SE:VICO) ) is now available. Vicore...
11-13 09:02
An Overview of Sunrun's Earnings
Sunrun (NASDAQ:RUN) will release its quarterly earnings report on Thursday, 202...
11-06 00:03
Vicore Pharma to Present at Key Healthcare Conferences
The latest announcement is out from Vicore Pharma Holding AB ( ($SE:VICO) ). Vi...
11-05 16:03
Vicor Adopts Silvaco’s Victory TCAD™ 3D Simulation Solution for Accurate Power Device Modeling and Simulation
Silvaco has announced that Vicor Corporation has adopted its Victory™ TCAD 3D simulation solution for power device modeling and simulation, enabling more accurate prediction of real-world performance compared to traditional 2D methods. This partnership accelerates design cycles, enhances reliability, and supports industry trends toward miniaturization and integration.
10-28 13:15
美股周涨跌榜 | 卡朋特科技周涨32%，Q3净利润1.23亿美元； SanDisk Corp周涨32.8%创历史新高
卡朋特科技周涨32%，Q3净利润1.23亿美元，同比增加45.22%； 存储芯片遇“超级周期”，SanDisk Corp周涨32.8%创历史新高>>
10-25 10:05
Why Did Vicor Stock (VICR) Jump 30%?
Shares of high-performance power systems manufacturer Vicor ($VICR) jumped over...
10-23 22:49
美股牛股 | ARMP大涨超103%！抗血感染药物在中期试验中显示出积极结果；直觉外科公司涨近14%
ARMP大涨超103%！抗血感染药物在中期试验中显示出积极结果；直觉外科公司涨近14%，Q3业绩表现优异，远超市场预期>>
10-23 14:51
美股大行评级 | 超配！万事达、Visa、Block获多家机构首予评级；奈飞、德州仪器遭多家机构下调目标价
今日重点评级关注：Canaccord Genuity：维持ATAI Life Sciences"买入"评级，目标价从11美元升至14美元；麦格理：维持Cleanspark"跑赢大市"评级，目标价从20美元升至30美元
10-23 10:06
